About Sudo Biosciences
Sudo Biosciences is a private company based in Carmel, Indiana, incorporated in 2020 in Delaware. It has reported $85,846,587 raised in two offerings on Form D since May 2021. Its chief executive is Scott Byrd.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Dec 15, 2023 | Dec 28, 2023amended Feb 15, 2024 | $63,596,587of $161.7M target | 15 | $4.2M | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Apr 20, 2021 | May 5, 2021amended Mar 2, 2022 | $22,250,000fully sold | 6 | $3.7M | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Total, two offerings | $85,846,587 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Sudo Biosciences's Form D filed Feb 15, 2024.
EF
Edd Fleming
Director
CG
DJ
David Johnson
Director
SB
Scott Byrd
Chief Executive Officer and director
SF
Shinichiro Fuse
Director
DE
Daniel Estes
Director
Earlier filings also listed Jim Bristol (director, last listed Mar 2022).